Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S. Viswanathan, Stuart L. Schreiber, Matthew J. Ryan et al.|Nature|2017Cited by 2k
Discovering the anticancer potential of non-oncology drugs by systematic viability profilingSteven M. Corsello, Todd R. Golub, Rohith T. Nagari et al.|Nature Cancer|2020Cited by 880
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapyMatthew Holderfield, Elena S. Koltun, Mallika Singh et al.|Nature|2024Cited by 319
Massively parallel pooled screening reveals genomic determinants of nanoparticle deliveryNatalie Boehnke, Paula T. Hammond, Joelle P. Straehla et al.|Science|2022Cited by 195
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N. Wasko, Miroslav Sekulic, Jingjing Jiang et al.|Nature|2024Cited by 175